loading
전일 마감가:
$9.97
열려 있는:
$9.92
하루 거래량:
204.74K
Relative Volume:
1.08
시가총액:
$475.15M
수익:
$62.02M
순이익/손실:
$-45.65M
주가수익비율:
0.8486
EPS:
11.36
순현금흐름:
$-9.60M
1주 성능:
+0.78%
1개월 성능:
+11.37%
6개월 성능:
+5.76%
1년 성능:
-6.18%
1일 변동 폭
Value
$9.59
$9.97
1주일 범위
Value
$9.25
$10.10
52주 변동 폭
Value
$7.44
$11.71

Theravance Biopharma Inc Stock (TBPH) Company Profile

Name
명칭
Theravance Biopharma Inc
Name
전화
650-808-6000
Name
주소
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Name
직원
99
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
TBPH's Discussions on Twitter

TBPH을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
TBPH 9.64 475.15M 62.02M -45.65M -9.60M 11.36
VRTX 449.37 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.04 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 595.85 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.02 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.14 24.89B 3.30B -501.07M 1.03B 11.54

Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-05-23 개시 SVB Leerink Outperform
2021-11-05 업그레이드 JP Morgan Underweight → Neutral
2021-09-15 다운그레이드 JP Morgan Overweight → Underweight
2021-08-25 다운그레이드 Morgan Stanley Overweight → Underweight
2021-08-24 다운그레이드 Cowen Outperform → Market Perform
2020-10-14 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-07-07 개시 JP Morgan Overweight
2020-06-15 개시 Morgan Stanley Equal-Weight
2020-05-13 개시 Cowen Outperform
2020-01-08 재확인 H.C. Wainwright Buy
2019-11-06 업그레이드 Robert W. Baird Underperform → Neutral
2019-10-29 개시 H.C. Wainwright Buy
2018-03-29 재개 Piper Jaffray Overweight
2017-08-17 개시 Evercore ISI Outperform
2017-06-16 개시 Cantor Fitzgerald Overweight
2017-05-11 재확인 Needham Buy
2016-12-21 개시 Needham Buy
2016-11-03 개시 Piper Jaffray Overweight
2016-10-12 다운그레이드 Robert W. Baird Neutral → Underperform
2016-08-03 다운그레이드 BofA/Merrill Neutral → Underperform
2016-06-20 개시 Guggenheim Buy
2016-06-20 재확인 Leerink Partners Outperform
2016-05-12 개시 Leerink Partners Outperform
2016-05-05 다운그레이드 BofA/Merrill Buy → Neutral
2015-02-03 업그레이드 Robert W. Baird Underperform → Neutral
모두보기

Theravance Biopharma Inc 주식(TBPH)의 최신 뉴스

pulisher
Nov 20, 2024

Multiple System Atrophy Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma - The Globe and Mail

Nov 20, 2024
pulisher
Nov 20, 2024

Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Theravance Biopharma to Present at Evercore HealthCONx Conference | TBPH Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 19, 2024

Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 19, 2024
pulisher
Nov 15, 2024

(TBPH) Investment Report - Stock Traders Daily

Nov 15, 2024
pulisher
Nov 15, 2024

Theravance Biopharma Inc (TBPH) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

Madison Avenue Partners, LP Expands Stake in Theravance Biopharm - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Theravance Biopharma Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Analysts Set Theravance Biopharma, Inc. (NASDAQ:TBPH) PT at $13.75 - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Theravance Biopharma SVP Rhonda Farnum sells $36,000 in shares - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

Theravance Biopharma SVP Rhonda Farnum sells $36,000 in shares By Investing.com - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Theravance Biopharma (NASDAQ:TBPH) Stock Price Crosses Above Fifty Day Moving AverageTime to Sell? - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Initiatives - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Theravance Biopharma Inc (TBPH) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

Theravance Biopharma’s Third Quarter 2024 Financial Insights - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Theravance Biopharma Q3 2024 Earnings: Revenue Surpasses Estimat - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Theravance Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

With Theravance Biopharma, Inc. (NASDAQ:TBPH) It Looks Like You'll Get What You Pay For - Simply Wall St

Nov 12, 2024
pulisher
Nov 12, 2024

Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value - PR Newswire

Nov 12, 2024
pulisher
Nov 11, 2024

What To Expect From Theravance Biopharma Inc (TBPH) Q3 2024 Earnings - GuruFocus.com

Nov 11, 2024
pulisher
Nov 11, 2024

Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance - Yahoo Finance

Nov 11, 2024
pulisher
Nov 10, 2024

Theravance Biopharma (TBPH) Scheduled to Post Earnings on Tuesday - Defense World

Nov 10, 2024
pulisher
Nov 08, 2024

5 Small Drug Stocks to Buy as Trump Gets Re-Elected - Yahoo Finance

Nov 08, 2024
pulisher
Nov 05, 2024

Theravance Biopharma (TBPH) Set to Announce Quarterly Earnings on Tuesday - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Theravance Biophar - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

(TBPH) Proactive Strategies - Stock Traders Daily

Nov 04, 2024
pulisher
Oct 26, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Sold by SG Americas Securities LLC - MarketBeat

Oct 26, 2024
pulisher
Oct 24, 2024

When (TBPH) Moves Investors should Listen - Stock Traders Daily

Oct 24, 2024
pulisher
Oct 24, 2024

Theravance Biopharma to Report Third Quarter 2024 Financial Results on November 12, 2024 - StockTitan

Oct 24, 2024
pulisher
Oct 23, 2024

Q3 EPS Estimate for Theravance Biopharma Boosted by Analyst - MarketBeat

Oct 23, 2024
pulisher
Oct 23, 2024

Brokerages Set Theravance Biopharma, Inc. (NASDAQ:TBPH) PT at $13.75 - Defense World

Oct 23, 2024
pulisher
Oct 22, 2024

What is Zacks Research's Estimate for TBPH Q4 Earnings? - MarketBeat

Oct 22, 2024
pulisher
Oct 20, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Average Rating of "Hold" by Analysts - MarketBeat

Oct 20, 2024
pulisher
Oct 20, 2024

The Manufacturers Life Insurance Company Decreases Stake in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

Oct 20, 2024
pulisher
Oct 19, 2024

Theravance study shows YUPELRI improves COPD lung function By Investing.com - Investing.com Australia

Oct 19, 2024
pulisher
Oct 19, 2024

Theravance Biopharma (NASDAQ:TBPH) Shares Pass Below 200 Day Moving AverageHere's What Happened - MarketBeat

Oct 19, 2024
pulisher
Oct 18, 2024

Theravance study shows YUPELRI improves COPD lung function - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Theravance Announces Publication of YUPELRI® (revefenacin) Area Under the Curve Spirometry Analysis in the International Journal of Chronic Obstructive Pulmonary Disease - StockTitan

Oct 18, 2024
pulisher
Oct 14, 2024

Where are the Opportunities in (TBPH) - Stock Traders Daily

Oct 14, 2024
pulisher
Oct 11, 2024

Dimensional Fund Advisors LP Has $2.80 Million Stake in Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

Theravance Biopharma (STU:0TB) Price-to-Operating-Cash-Flow : (As of Oct. 10, 2024) - GuruFocus.com

Oct 10, 2024
pulisher
Oct 07, 2024

Squarepoint Ops LLC Takes $986,000 Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat

Oct 07, 2024
pulisher
Oct 06, 2024

Bank of Montreal Can Raises Stock Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat

Oct 06, 2024
pulisher
Oct 04, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Stock Holdings Lifted by Marshall Wace LLP - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

(TBPH) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Oct 03, 2024
pulisher
Oct 02, 2024

XTX Topco Ltd Purchases New Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

Oct 02, 2024
pulisher
Sep 28, 2024

Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y - MSN

Sep 28, 2024
pulisher
Sep 25, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Rhumbline Advisers Sells 15,095 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

Sep 25, 2024

Theravance Biopharma Inc (TBPH) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Theravance Biopharma Inc 주식 (TBPH) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Samaha Eli
10% Owner
Aug 07 '24
Buy
7.80
999,800
7,798,440
9,511,150
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Jul 10 '24
Sale
9.00
4,000
36,000
335,965
Samaha Eli
10% Owner
May 01 '24
Buy
8.75
1,499,124
13,117,335
8,511,350
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Feb 22 '24
Sale
8.71
1,254
10,922
311,733
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):